Germany's largest pharmaceutical company Boehringer Ingelheim on Wednesday reported a currency-adjusted 6.1% gain in 2024 ...

Boehringer Laboratory Illustrative image Number of patients reached in 2024 jumps 8% to 66 million R&D investments rise to ...

Nearly three-quarters of the world’s billionaires are between the ages of 50 and 79. Just 12% are under 50. The rarest of all ...

NBE Therapeutics (NBE) a wholly owned subsidiary of Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel ...

Boehringer Ingelheim is pumping funds into the still-hot antibody-drug conjugate space, committing 27 million Swiss francs ...

Boehringer Ingelheim picked a challenging day to reveal its 2024 financial results and guidance for this year. | Boehringer ...

Germany's largest pharma company, today reported a currency-adjusted 6.1% gain in full-year 2024 revenues, buoyed by its ...

Wealth rating firm Forbes states that most billionaires worldwide fall within the age range of 50 to 79. However, 12% of billionaires are younger than this range, achieving billionaire status by the ...

At Reuters Pharma USA in Philadelphia, editor-in-chief Jonah Comstock caught up with Brian Hilberdink, the new head of US ...

The term billionaire is not a small feat, and most times can be an accumulation of one's lifetime's work yielding in their ...

With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...

New evidence suggests that factors other than the percentage of weight loss should be considered when determining the success ...